From: Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers
 | Gel segment No. | Protein | Residues | Peptide sequence | Protein accessions |
---|---|---|---|---|---|
Brain sample | 5 | Nlgn1 | 267–279 | GNYGLLDLIQALR | Q8N2Q7 |
 |  | Nlgn1 | 295–320 | ITVFGSGAGGScVNLLTLSHYSEGNR | Q8N2Q7 |
 |  | Nlgn1-2 | 252–266 | LGVLGFLSTGDQAAK | Q8N2Q7; Q8NFZ4 |
 |  | Nlgn1-2 | 589–601 | TGDPNQPVPQDTK | Q8N2Q7; Q8NFZ4 |
 |  | Nlgn1-3 | 672–683 | DQLYLHIGLKPR | Q8N2Q7; Q9NZ94 |
 |  | Nlgn2 | 450–469 | TLLALFTDHQWVAPAVATAK | Q8NFZ4 |
 | 6 | Nlgn2 | 57–72 | ELNNEILGPVVQFLGVPYATPPLGAR | Q8NFZ4 |
 |  | Nlgn2 | 259–286 | ITIFGSGAGAScVNLLILSHHSEGLFQK | Q8NFZ4 |
 |  | Nlgn2 | 336–346 | ELVDQDVQPAR | Q8NFZ4 |
 |  | Nlgn2 | 315–330 | VGcDREDSAEAVEcLR | Q8NFZ4 |
CSF sample | 12 | Nlgn1 | 267–279 | GNYGLLDLIQALR | Q8N2Q7 |
 |  | Nlgn1 | 295–320 | ITVFGSGAGGScVNLLTLSHYSEGNR | Q8N2Q7 |
 |  | Nlgn1 | 336–351 | AIAQSGTALSSWAVSFQPAK | Q8N2Q7 |
 | 12–13 | Nlgn1-2 | 252–266 | LGVLGFLSTGDQAAK | Q8N2Q7; Q8NFZ4 |
 | 13 | Nlgn1-2 | 589–601 | TGDPNQPVPQDTK | Q8N2Q7; Q8NFZ4 |
 |  | Nlgn1-3 | 672–683 | DQLYLHIGLKPR | Q8N2Q7; Q9NZ94 |
 |  | Nlgn2 | 336–346 | ELVDQDVQPAR | Q8NFZ4 |